Impact of oxLDL and LPS on C-type natriuretic peptide system is different between THP-1 cells and human peripheral blood monocytic cells

Cellular Physiology and Biochemistry

Volumn 30, Issue 1, 2012, Pages 199-209

  Bruckmeier, Martin ^a   Kuehnl, Andreas ^a   Culmes, Mihaela ^a   Pelisek, Jaroslav ^a   Eckstein, Hans Henning ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atherosclerosis; C type natriuretic peptide; Gene expression; Monocytes; THP 1 cells

Indexed keywords

CD14 ANTIGEN; CD68 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NATRIURETIC PEPTIDE TYPE C; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; CELL CULTURE; CELL LINE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84863433994     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000339044     Document Type: Article

References (62)

1. WHO: Global burden disease DTH6 2008.xls. 2011; Available from: http://www.who.int/research/en/.
2. Hansson GK, Libby P: The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006;6:508-519. (Pubitemid 43980523)
3. Saha P, Modarai B, Humphries J , Mattock K, Waltham M, Burnand KG, Smith A: The monocyte/macrophage as a therapeutic target in atherosclerosis. Curr Opin Pharmacol 2009;9:109-118.
4. Chisolm GM, 3rd, Chai Y: Regulation of cell growth by oxidized LDL. Free Radic Biol Med 2000;28:1697-1707. (Pubitemid 30628656)
5. Galkina E, Ley K: Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 2009;27:165-197.
6. Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM: Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 2009;191:341-366.
7. Nishikimi T, Kuwahara K, Nakao K: Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol 2011; 7:131-140.
8. Woodard GE, Rosado JA: Natriuretic peptides in vascular physiology and pathology. Int Rev Cell Mol Biol 2008;268:59-93.
9. Sudoh T, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990;168:863-870. (Pubitemid 20164622)
10. Inoue K, Naruse K, Yamagami S, Mitani H, Suzuki N, Takei Y: Four functionally distinct C-type natriuretic peptides found in fish reveal evolutionary history of the natriuretic peptide system. Proc Natl Acad Sci USA 2003;100:10079-10084. (Pubitemid 37087070)
11. Pelisek J , Fuchs AT, Kuehnl A, Tian W, Kuhlmann MT, Rolland PH, Mekkaoui C, Gaedtke L, Nikol S. C-type natriuretic peptide for reduction of restenosis: gene transfer is superior over single peptide administration. J Gene Med 2006;8(7):835-844. (Pubitemid 44097139)
12. Kuehnl A, Pelisek J , Tian W, Kuhlmann M, Rolland PH, Mekkaoui C, Fuchs A, Nikol S: C-type natriuretic peptide inhibits constrictive remodeling without compromising re-endothelialization in balloon-dilated renal arteries. J Endovasc Ther 2005;12:171-182. (Pubitemid 40517050)
13. Saha S, Li Y, Lappas G, Anand-Srivastava MB. Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Gialpha protein. J Mol Cell Cardiol 2008;44:336-344.
14. Pagel-Langenickel I, Buttgereit J , Bader M, Langenickel TH: Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy. J Mol Med 2007;85:797-810. (Pubitemid 47077112)
15. Bartels CF, Bukulmez H, Padayatti P, Rhee DK, van Ravenswaaij-Arts C, Pauli RM, Mundlos S, Chitayat D, Shih LY, Al-Gazali LI, Kant S, Cole T, Morton J , Cormier-Daire V, Faivre L, Lees M, Kirk J , Mortier GR, Leroy J , Zabel B, Kim CA, Crow Y, Braverman NE, van den Akker F, Warman ML: Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet 2004;75:27-34. (Pubitemid 38801898)
16. Teixeira CC, Agoston H, Beier F: Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification. Dev Biol 2008;319:171-178.
17. Walther T, Stepan H: C-type natriuretic peptide in reproduction, pregnancy and fetal development. J Endocrinol 2004;180:17-22. (Pubitemid 38180753)
18. Walther T, Stepan H: C-type natriuretic peptide in reproduction, pregnancy and fetal development. J Endocrinol 2004;180: 7-22.
19. Schmidt H, Stonkute A, Juttner R, Koesling D, Friebe A, Rathjen FG: C-type natriuretic peptide (CNP) is a bifurcation factor for sensory neurons. Proc Natl Acad Sci USA 2009;106:16847-16852.
20. Doi K, Ikeda T, Itoh H, Ueyama K, Hosoda K, Ogawa Y, Yamashita J , Chun TH, Inoue M, Masatsugu K, Sawada N, Fukunaga Y, Saito T, Sone M, Yamahara K, Kook H, Komeda M, Ueda M, Nakao K: C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization. Arterioscler Thromb Vase Biol 2001;21:930-936. (Pubitemid 34168648)
21. Hu P, Lu L, Hu B, Qin YH: Renal action of C-type natriuretic peptide: advocating the isolated perfused rat kidney model. Saudi J Kidney Dis Transpl 2010;21:613-620.
22. Sabbatini ME, Rodriguez MR, Dabas P, Vatta MS, Bianciotti LG: C-type natriuretic peptide stimulates pancreatic exocrine secretion in the rat: role of vagal afferent and efferent pathways. Eur J Pharmacol 2007;577:192-202. (Pubitemid 47632536)
23. Palmer SC, Prickett TC, Espiner EA, Yandle TG, Richards AM: Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function. Hypertension 2009;54:612-618.
24. Pelisek J , Kuehnl A, Rolland PH, Mekkaoui C, Fuchs A, Walker GF, Ogris M, Wagner E, Nikol S: Functional analysis of genomic DNA, cDNA, and nucleotide sequence of the mature C-type natriuretic peptide gene in vascular cells. Arterioscler Thromb Vase Biol 2004;24:1646-1651. (Pubitemid 39180889)
25. Federico C: Natriuretic Peptide system and cardiovascular disease. Heart Views 2010;11:10-15.
26. Castro GP, Dussin LH, Wender OB, Barbosa GV, Saadi EK: [Comparative analysis of the flows of left internal thoracic artery grafts dissected in the pedicled versus skeletonized manner for myocardial revascularization surgery J . Arq Bras Cardiol 2005;84:261-266.
27. Sandow SL, Tare M: C-type natriuretic peptide: a new endothelium-derived hyperpolarizing factor? Trends Pharmacol Sci 2007;28(2):61-67. (Pubitemid 46161839)
28. Simon A, Harrington EO, Liu GX, Koren G, Choudhary G: Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization. Am J Physiol Lung Cell Mol Physiol 2009;296(2):L248-256.
29. Anand-Srivastava MB: Natriuretic peptide receptor-C signaling and regulation. Peptides 2005;26:1044-1059. (Pubitemid 40725375)
30. Kiemer AK, Lehner MD, Hartung T, Vollmar AM: Inhibition of cyclooxygenase-2 by natriuretic peptides. Endocrinology 2002;143:846-852. (Pubitemid 34164034)
31. Hashim S, Li Y, Anand-Srivastava MB: Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gialpha protein/MAP kinase/PI3-kinase/AKT pathways. Am J Physiol Heart Circ Physiol 2006;291:H3144-3153. (Pubitemid 44904118)
32. Schulz S: C-type natriuretic peptide and guanylyl cyclase B receptor. Peptides 2005;26:1024-1034. (Pubitemid 40725373)
33. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K: Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980;26:171-176. (Pubitemid 10086416)
34. Qin Z: The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis 2011;221:2-11.
35. Li M, Lin J , Wang Z, He S, Ma X, Li D: Oxidized low-density lipoprotein-induced proinflammatory cytokine response in macrophages are suppressed by CD4CD25(+)Foxp3(+) regulatory T cells through downregulating toll like receptor 2-mediated activation of NF-kappaB. Cell Physiol Biochem 2010;25:649-656.
36. Shiffman D, Mikita T, Tai JT, Wade DP, Porter JG, Seilhamer J J , Somogyi R, Liang S, Lawn RM: Large scale gene expression analysis of cholesterol-loaded macrophages. J Biol Chem 2000;275:37324-37332. (Pubitemid 32004834)
37. Whatling C, Bjork H, Gredmark S, Hamsten A, Eriksson P: Effect of macrophage differentiation and exposure to mildly oxidized LDL on the proteolytic repertoire of THP-1 monocytes. J Lipid Res 2004;45:1768-1776. (Pubitemid 39296217)
38. Mikita T, Porter G, Lawn RM, Shiffman D. Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus. J Biol Chem 2001; 276(49): 45729-39.
39. Xue X, Lai KT, Huang JF, Gu Y, Karlsson L, Fourie A: Anti-inflammatory activity in vitro and in vivo of the protein farnesyltransferase inhibitor tipifarnib. J Pharmacol Exp Ther 2006;317:53-60.
40. Jovinge S, Ares MP, Kallin B, Nilsson J : Human monocytes/macrophages release TNF-alpha in response to Ox-LDL. Arterioscler Thromb Vase Biol 1996;16:1573-1579. (Pubitemid 26427613)
41. Rinne H: Taschenbuch der Statistik. 4th ed. Frankfurt am Main: Wissenschaftlicher Verlag Harri Deutsch GmbH; 2008.
42. Martens JS, Reiner NE, Herrera-Velit P, Steinbrecher UP: Phosphatidylinositol 3-kinase is involved in the induction of macrophage growth by oxidized low density lipoprotein. J Biol Chem 1998;273:4915-4920. (Pubitemid 28108643)
43. Martens JS, Lougheed M, Gomez-Munoz A, Steinbrecher UP: A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein. J Biol Chem 1999;274:10903-10910.
44. Yamamoto K, Ikeda U, Shimada K: Role of mechanical stress in monocytes/macrophages: implications for atherosclerosis. Curr Vase Pharmacol 2003;1:315-319.
45. Graziani-Bowering GM, Graham JM, Filion LG: A quick, easy and inexpensive method for the isolation of human peripheral blood monocytes. J Immunol Methods 1997;207:157-168. (Pubitemid 27455875)
46. de Carvalho CM, Bonnefont-Rebeix C, Picandet S, Bernaud J , Phothirath P, Chabanne L, Marchal T, Magnol JP, Rigal D: Evaluation of elutriation and magnetic microbead purification of canine monocytes. Vet Immunol Immunopathol 2004;101:171-178. (Pubitemid 39178376)
47. Lund PK, Joo GB, Westvik AB, Ovstebo R, Kierulf P: Isolation of monocytes from whole blood by density gradient centrifugation and counter-current elutriation followed by cryopreservation: six years' experience. Scand J Clin Lab Invest 2000;60:357-365.
48. Sugiyama S, Kugiyama K, Matsumura T, Suga S, Itoh H, Nakao K, Yasue H: Lipoproteins regulate C-type natriuretic peptide secretion from cultured vascular endothelial cells. Arteriosclerosis, thrombosis, and vascular biology 1995;15:1968-1974.
49. Sellitti DF, Koles N, Mendonca MC: Regulation of C-type natriuretic peptide expression. Peptides 2011;32:1964-1971.
50. Vollmar AM, Schulz R: Expression and differential regulation of natriuretic peptides in mouse macrophages. J Clin Invest 1995;95:2442-2450.
51. Kubo A, Isumi Y, Ishizaka Y, Tomoda Y, Kangawa K, Dohi K, Matsuo H, Minamino N: C-type natriuretic peptide is synthesized and secreted from leukemia cell lines, peripheral blood cells, and peritoneal macrophages. Exp Hematol 2001;29:609-615. (Pubitemid 32463898)
52. Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, Nakao K: Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 1993;133:3038-3041. (Pubitemid 24000770)
53. Miyoshi M, Watanabe T: Role of anterior hypothalamic natriuretic peptide in lipopolysaccharide-induced fever in rats. Eur J Appl Physiol 2010;109:49-57.
54. Bas S, Neff L, Vuillet M, Spenato U, Seya T, Matsumoto M, Gabay C: The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. J Immunol 2008;180:1158-1168.
55. Terkeltaub R, Banka CL, Solan J , Santoro D, Brand K, Curtiss LK: Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler Thromb 1994;14:47-53.
56. Ahmadzadeh E, Zarkesh-Esfahani H, Roghanian R, Akbar FN: Comparison of Helicobacter pylori and Escherichia coli in induction of TNF-alpha mRNA from human peripheral blood mononuclear cells. Indian J Med Microbiol 2010;28:233-237.
57. Caruso R, Stolfi C, Sarra M, Rizzo A, Fantini MC, Pallone F, MacDonald TT, Monteleone G: Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3. Blood 2009;113:3512-3519.
58. Molnarfi N, Gruaz L, Dayer JM, Burger D: Opposite regulation of IL-lbeta and secreted IL-1 receptor antagonist production by phosphatidylinositide-3 kinases in human monocytes activated by lipopolysaccharides or contact with T cells. J Immunol 2007;178:446-454. (Pubitemid 46033628)
59. Perez-Perez GI, Shepherd VL, Morrow JD, Blaser MJ: Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect Immun 1995;63(4):1183-1187.
60. Levitan I, Volkov S, Subbaiah PV. Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxid Redox Signal 2010;13:39-75.
61. Ardans JA, Economou AP, Martinson JM Jr., Zhou M, Wahl LM: Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and-9 by activated monocytes. J Leukoc Biol 2002;71:1012-1018.
62. Qiu G, Ho AC, Yu W, Hill JS: Suppression of endothelial or lipoprotein lipase in THP-1 macrophages attenuates proinflammatory cytokine secretion. J Lipid Res 2007;48:385-394. (Pubitemid 46220605)